VERACYTE, INC. Increase (Decrease) in Deferred Revenue
VERACYTE, INC. (VCYT) reported Increase (Decrease) in Deferred Revenue of $10.00 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2015-03-25
- VERACYTE, INC. increase (decrease) in deferred revenue for the quarter ending 2014-03-31 was $10.00M.
- VERACYTE, INC. increase (decrease) in deferred revenue for the quarter ending 2012-12-31 was $0.00.
- VERACYTE, INC. increase (decrease) in deferred revenue for fiscal 2012 was $10.00M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|
| 2014-03-31 | $10.00M 10-Q · filed 2014-05-09 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $10.00M 10-K · filed 2015-03-25 | |
| 2012-09-30 | $10.00M 10-Q · filed 2013-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |